Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for shares of Jazz Pharmaceuticals in a ...

The cannabis-derived compound cannabidiol (CBD) is gaining traction as a treatment for a broad range of conditions, but it's ...

After bursting onto the scene several years ago with considerable fanfare, much of the hype about cannabis stocks has quietly died down, and ...

Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus rating of “Moderate Buy” from ...

Jones Soda Co. today announced that its strategic growth strategy focusing on key new beverage segments is successfully increasing its sales and distribution network, including securing two new Direct ...

Jazz Pharma has agreed a $7.2 billion deal to by GW Pharmaceuticals and its pioneering cannabis-derived medicines, headed by childhood epilepsy drug Epidiolex. Nasdaq-listed GW is in line for $220 ...

Currency traders work near a screen showing the Korea Composite Stock Price Index (KOSPI) at the foreign exchange dealing room of the KEB Hana Bank headquarters in Seoul, South Korea, Tuesday ...

Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis.

After hours: March 20 at 6:09:08 p.m. EDT Loading Chart for JAZZ ...